147 related articles for article (PubMed ID: 24716976)
41. Peroxisome proliferator-activated receptor-gamma and growth inhibition by its ligands in prostate cancer.
Nagata D; Yoshihiro H; Nakanishi M; Naruyama H; Okada S; Ando R; Tozawa K; Kohri K
Cancer Detect Prev; 2008; 32(3):259-66. PubMed ID: 18789607
[TBL] [Abstract][Full Text] [Related]
42. Combinational effect of PPARγ agonist and RXR agonist on the growth of SGC7901 gastric carcinoma cells in vitro.
Liu Y; Zhu ZA; Zhang SN; Mou J; Liu L; Cui T; Pei DS
Tumour Biol; 2013 Aug; 34(4):2409-18. PubMed ID: 23605322
[TBL] [Abstract][Full Text] [Related]
43. Peroxisome proliferator-activated receptor gamma ligand troglitazone induces cell cycle arrest and apoptosis of hepatocellular carcinoma cell lines.
Yoshizawa K; Cioca DP; Kawa S; Tanaka E; Kiyosawa K
Cancer; 2002 Nov; 95(10):2243-51. PubMed ID: 12412180
[TBL] [Abstract][Full Text] [Related]
44. Characteristics of the peroxisome proliferator activated receptor gamma (PPARgamma) ligand induced apoptosis in colon cancer cells.
Shimada T; Kojima K; Yoshiura K; Hiraishi H; Terano A
Gut; 2002 May; 50(5):658-64. PubMed ID: 11950812
[TBL] [Abstract][Full Text] [Related]
45. Induction of differentiation and peroxisome proliferator-activated receptor gamma expression in colon cancer cell lines by troglitazone.
Kato M; Kusumi T; Tsuchida S; Tanaka M; Sasaki M; Kudo H
J Cancer Res Clin Oncol; 2004 Feb; 130(2):73-9. PubMed ID: 14634802
[TBL] [Abstract][Full Text] [Related]
46. Peroxisome proliferator-activated receptor γ ligand troglitazone and TRAIL synergistically induce apoptosis.
Koyama M; Sowa Y; Horinaka M; Goda AE; Fujiwara J; Sakai T
Oncol Rep; 2014 Feb; 31(2):947-54. PubMed ID: 24276615
[TBL] [Abstract][Full Text] [Related]
47. Growth arrest by troglitazone is mediated by p27Kip1 accumulation, which results from dual inhibition of proteasome activity and Skp2 expression in human hepatocellular carcinoma cells.
Motomura W; Takahashi N; Nagamine M; Sawamukai M; Tanno S; Kohgo Y; Okumura T
Int J Cancer; 2004 Jan; 108(1):41-6. PubMed ID: 14618613
[TBL] [Abstract][Full Text] [Related]
48. Small molecule agonists of PPAR-γ exert therapeutic effects in esophageal cancer.
Sawayama H; Ishimoto T; Watanabe M; Yoshida N; Sugihara H; Kurashige J; Hirashima K; Iwatsuki M; Baba Y; Oki E; Morita M; Shiose Y; Baba H
Cancer Res; 2014 Jan; 74(2):575-85. PubMed ID: 24272485
[TBL] [Abstract][Full Text] [Related]
49. Peroxisome proliferator activator receptor-gamma agonists and 15-deoxy-Delta(12,14)(12,14)-PGJ(2) induce apoptosis in normal and malignant B-lineage cells.
Padilla J; Kaur K; Cao HJ; Smith TJ; Phipps RP
J Immunol; 2000 Dec; 165(12):6941-8. PubMed ID: 11120820
[TBL] [Abstract][Full Text] [Related]
50. Specific thiazolidinediones inhibit ovarian cancer cell line proliferation and cause cell cycle arrest in a PPARγ independent manner.
Al-Alem L; Southard RC; Kilgore MW; Curry TE
PLoS One; 2011 Jan; 6(1):e16179. PubMed ID: 21283708
[TBL] [Abstract][Full Text] [Related]
51. The effect of peroxisome proliferator-activated receptor-gamma ligand on urological cancer cells.
Yoshimura R; Matsuyama M; Hase T; Tsuchida K; Kuratsukuri K; Kawahito Y; Sano H; Segawa Y; Nakatani T
Int J Mol Med; 2003 Dec; 12(6):861-5. PubMed ID: 14612958
[TBL] [Abstract][Full Text] [Related]
52. Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)-Troglitazone-induced Apoptosis in Prostate Cancer Cells Involve AMP-activated Protein Kinase.
Santha S; Viswakarma N; Das S; Rana A; Rana B
J Biol Chem; 2015 Sep; 290(36):21865-75. PubMed ID: 26198640
[TBL] [Abstract][Full Text] [Related]
53. Activation of peroxisome proliferator-activated receptor-gamma stimulates the growth arrest and DNA-damage inducible 153 gene in non-small cell lung carcinoma cells.
Satoh T; Toyoda M; Hoshino H; Monden T; Yamada M; Shimizu H; Miyamoto K; Mori M
Oncogene; 2002 Mar; 21(14):2171-80. PubMed ID: 11948400
[TBL] [Abstract][Full Text] [Related]
54. Regulation of p53 expression and apoptosis by vault RNA2-1-5p in cervical cancer cells.
Kong L; Hao Q; Wang Y; Zhou P; Zou B; Zhang YX
Oncotarget; 2015 Sep; 6(29):28371-88. PubMed ID: 26318295
[TBL] [Abstract][Full Text] [Related]
55. Cytoprotective effect of tauroursodeoxycholate on hepatocyte apoptosis induced by peroxisome proliferator-activated receptor gamma ligand.
Nonaka M; Tazuma S; Hyogo H; Kanno K; Chayama K
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e198-206. PubMed ID: 17868335
[TBL] [Abstract][Full Text] [Related]
56. Relationship between peroxisome proliferator-activated receptor-gamma expression and differentiation of human esophageal squamous cell carcinoma.
Takashima T; Fujiwara Y; Hamaguchi M; Sasaki E; Tominaga K; Watanabe T; Oshitani N; Higuchi K; Arakawa T
Oncol Rep; 2005 Apr; 13(4):601-6. PubMed ID: 15756430
[TBL] [Abstract][Full Text] [Related]
57. Estrogen-dependent regulation of PPAR-gamma signaling on collagen biosynthesis in adenocarcinoma endometrial cells.
Surazynski A; Jarzabek K; Miltyk W; Wolczynski S; Palka J
Neoplasma; 2009; 56(5):448-54. PubMed ID: 19580348
[TBL] [Abstract][Full Text] [Related]
58. Ligand activation of peroxisome proliferator-activated receptor gamma induces apoptosis of leukemia cells by down-regulating the c-myc gene expression via blockade of the Tcf-4 activity.
Yamakawa-Karakida N; Sugita K; Inukai T; Goi K; Nakamura M; Uno K; Sato H; Kagami K; Barker N; Nakazawa S
Cell Death Differ; 2002 May; 9(5):513-26. PubMed ID: 11973610
[TBL] [Abstract][Full Text] [Related]
59. Pioglitazone induces cell growth arrest and activates mitochondrial apoptosis in human uterine leiomyosarcoma cells by a peroxisome proliferator-activated receptor γ-independent mechanism.
Lützen U; Zhao Y; Lucht K; Zuhayra M; Marx M; Cascorbi I; Culman J
Naunyn Schmiedebergs Arch Pharmacol; 2017 Jan; 390(1):37-48. PubMed ID: 27664035
[TBL] [Abstract][Full Text] [Related]
60. Troglitazone, a ligand of peroxisome proliferator-activated receptor-{gamma}, stabilizes NUCB2 (Nesfatin) mRNA by activating the ERK1/2 pathway: isolation and characterization of the human NUCB2 gene.
Yamada M; Horiguchi K; Umezawa R; Hashimoto K; Satoh T; Ozawa A; Shibusawa N; Monden T; Okada S; Shimizu H; Mori M
Endocrinology; 2010 Jun; 151(6):2494-503. PubMed ID: 20427483
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]